ENLISTCELLS Trademark

Trademark Overview

On Friday, October 11, 2019, a trademark application was filed for ENLISTCELLS with the United States Patent and Trademark Office. The USPTO has given the ENLISTCELLS trademark a serial number of 88651885. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 4, 2023. This trademark is owned by Alloplex Biotherapeutics, Inc.. The ENLISTCELLS trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical purposes used to stimulate mononuclear cells for the treatment of cancer
enlistcells

General Information

Serial Number88651885
Word MarkENLISTCELLS
Filing DateFriday, October 11, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and ServicesCells for medical purposes used to stimulate mononuclear cells for the treatment of cancer
Pseudo MarkENLIST CELLS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlloplex Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWinchester, MA 01890
Party NameAlloplex Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWinchester, MA 01890

Trademark Events

Event DateEvent Description
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2023SOU EXTENSION 5 GRANTED
Tuesday, May 2, 2023SOU EXTENSION 5 FILED
Monday, May 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 4, 2022SOU EXTENSION 4 GRANTED
Tuesday, October 4, 2022SOU EXTENSION 4 FILED
Tuesday, October 4, 2022SOU TEAS EXTENSION RECEIVED
Thursday, April 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2022SOU EXTENSION 3 GRANTED
Tuesday, April 19, 2022SOU EXTENSION 3 FILED
Tuesday, April 19, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 12, 2021SOU EXTENSION 2 GRANTED
Tuesday, October 12, 2021SOU EXTENSION 2 FILED
Tuesday, October 12, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 7, 2021SOU EXTENSION 1 GRANTED
Wednesday, April 7, 2021SOU EXTENSION 1 FILED
Wednesday, April 7, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 21, 2020NON-FINAL ACTION E-MAILED
Tuesday, January 21, 2020NON-FINAL ACTION WRITTEN
Friday, January 10, 2020ASSIGNED TO EXAMINER
Thursday, October 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 15, 2019NEW APPLICATION ENTERED

Related Keywords

enlistcells cells treatment cancer mononuclear used medical purposes stimulate